The American Gastroenterological Association has published a tool for gastroenterologists in the early management of hepatitis C-positive patients though evidence-based, cost effective initial evaluations.
The Clinical Decision Tool for the Screening and Evaluation of Hepatitis C was published in a new paper in Gastroenterology. Each decision point in the tool was evaluated and graded for its strength of evidence and recommendation.
The AGA released the tool with the future delivery of accountable care in mind. It will address the financial pressures, risk contracting for population management and reimbursements tied to outcomes.
More Articles on Gastroenterology:
Salix Pharmaceuticals Buys Santarus for $32 Per Share
6 Vital Points on Gastroenterology Patient Engagement & Satisfaction From Dr. Gilbert Simoni
Cantel Medical Purchases Colonoscopy Flushing Device Company
The Clinical Decision Tool for the Screening and Evaluation of Hepatitis C was published in a new paper in Gastroenterology. Each decision point in the tool was evaluated and graded for its strength of evidence and recommendation.
The AGA released the tool with the future delivery of accountable care in mind. It will address the financial pressures, risk contracting for population management and reimbursements tied to outcomes.
More Articles on Gastroenterology:
Salix Pharmaceuticals Buys Santarus for $32 Per Share
6 Vital Points on Gastroenterology Patient Engagement & Satisfaction From Dr. Gilbert Simoni
Cantel Medical Purchases Colonoscopy Flushing Device Company